Ingres Corporation, the leading open source database management company
and pioneer of the New Economics of IT, today announced that AAH
Pharmaceuticals Ltd., the UK’s leading distributor of pharmaceutical and
healthcare products and services to pharmacies, hospitals, and doctors,
has significantly reduced operating costs with Ingres Database. Ingres
Database is the leading open source database that helps organizations
develop and manage business critical applications at an affordable cost.
With Ingres, AAH Pharmaceuticals has also improved the speed and
flexibility of its databases across the board.
“Our users are able to run ad-hoc queries that simply couldn’t be run
before, due to limitations on performance and functionality”
AAH has several business critical applications to ensure smooth,
beneficial relationships with manufacturers and suppliers. The
tech-savvy pharmaceutical company has seven databases for internal and
external use to manage data on stock, sales, invoicing, and customer
service. Thanks to the ease of management and robust performance of
Ingres, AAH is now able to run mission critical applications seamlessly
every day, on a future-proof platform.
“With Ingres, we have lowered our operation costs by as much as 50
percent compared to three years ago because we aren’t locked into
licensing anymore, but rather a subscription model where we pay per chip
we use,” said Richard David, database administrator, AAH.
In addition, AAH has improved the speed and flexibility of its
databases. The higher availability and significantly better response
time of the new system means that AAH can do more in much less time.
“Our users are able to run ad-hoc queries that simply couldn’t be run
before, due to limitations on performance and functionality,” said
Geraint Jones, product manager, AAH. “The scalability of the new systems
means we’re able to leave our databases up for longer and have shaved
just over an hour off our overnight batches.”